MN
Murali Narayana Rao Kurapati
About Murali Narayana Rao Kurapati
Data last updated:
Murali Narayana Rao Kurapati is a Director at Advanta Lifesciences Private Limited (since 2020), Designated Partner at Pharmedz Labs Llp (since 2020) and Designated Partner at Fortune Therapeutics Llp (since 2019). The companies operate in Pharma and Life Sciences. The largest current company by reported revenue is Advanta Lifesciences Private Limited at ₹5.70 Cr (FY 2024). Earlier, Murali Narayana Rao Kurapati was a Designated Partner at Hexamed Life Sciences Llp (2019–2020) and Director at Fortune Labs International Private Limited (from 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Advanta Lifesciences Private Limited U24297TG2020PTC144158 | Director | 23 Sep 2020 | 2020 | ₹5.70 Cr (FY 2024) | Active |
| Pharmedz Labs Llp AAI-2968 | Designated Partner | 07 Dec 2020 | 2017 | Active | |
| Fortune Therapeutics Llp AAM-8828 | Designated Partner | 02 Apr 2019 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Hexamed Life Sciences Llp AAO-2880 | Designated Partner | 28 Jun 2019 | 2019 | Active | |
 Fortune Labs International Private Limited U74999TG2019PTC131748 | Director | 01 Apr 2019 | 2019 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Murali Narayana Rao Kurapati
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shalini Rao Kurapati | 08890163 | Advanta Lifesciences Private Limited | Director |
| Vijay Kumar Gupta Kambampourambil | 08985992 | Pharmedz Labs Llp | Designated Partner |
| Naveen Kumar Goyal | 03626373 | Fortune Therapeutics Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Murali Narayana Rao Kurapati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Murali Narayana Rao Kurapati
Murali Narayana Rao Kurapati currently holds 3 directorships: Advanta Lifesciences Private Limited (Director, since 23 Sep 2020, revenue ₹5.70 Cr (FY 2024)); Pharmedz Labs Llp (Designated Partner, since 07 Dec 2020); Fortune Therapeutics Llp (Designated Partner, since 02 Apr 2019).
Murali Narayana Rao Kurapati was first appointed on 01 Apr 2019 as Director at Fortune Labs International Private Limited. The most recent appointment on record is 07 Dec 2020 at Pharmedz Labs Llp.
Murali Narayana Rao Kurapati held 2 earlier board appointments: Hexamed Life Sciences Llp (Designated Partner, 28 Jun 2019 to 18 Jan 2020); Fortune Labs International Private Limited (Director, from 01 Apr 2019).
The current boards of Murali Narayana Rao Kurapati's companies include Shalini Rao Kurapati (Advanta Lifesciences Private Limited), Vijay Kumar Gupta Kambampourambil (Pharmedz Labs Llp), Naveen Kumar Goyal (Fortune Therapeutics Llp).